153Sm-EDTMP in a patient suffering from colon cancer with bone metastasis;153Sm-EDTMP en un paciente afecto de cáncer de colon con metástasis ósea

Revista Espanola de Medicina Nuclear

Volumn 20, Issue 2, 2001, Pages 130-131

  Berna Roqueta L ^a   Martin F ^a   Cunill, C ^a   Nadal, C ^a   Javier Mateos, J ^a   Ortega, M ^a   Pons, F ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LEXIDRONAM SAMARIUM SM 153; (ETHYLENEDINITRILO) TETRAMETHYLENEPHOSPHONIC ACID; (ETHYLENEDINITRILO)-TETRAMETHYLENEPHOSPHONIC ACID; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; SAMARIUM;

ADULT; ARTICLE; BONE METASTASIS; BONE PAIN; CASE REPORT; COLON ADENOCARCINOMA; DRUG ACCUMULATION; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MALE; ADENOCARCINOMA; BETA RADIATION; BONE TUMOR; CERVICAL SPINE; GAMMA RADIATION; METASTASIS; PATHOLOGY; RECTUM TUMOR; SCAPULA; SCINTISCANNING; SKULL TUMOR; SPINAL CORD TUMOR;

ADENOCARCINOMA; ADULT; BETA RAYS; BONE NEOPLASMS; CERVICAL VERTEBRAE; GAMMA RAYS; HUMANS; MALE; ORGANOPHOSPHORUS COMPOUNDS; RADIOISOTOPES; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; SAMARIUM; SCAPULA; SKULL NEOPLASMS; SPINAL NEOPLASMS;

EID: 0035316634     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/s0212-6982(01)71941-6     Document Type: Article

References (2)

1. 153Sm-ethylenediaminetetramethy lenphosphonate (EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer 1997;33:1583-91.
2. 153-samarium lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol 1998;16:1574-81.